Trial to Evaluate the Efficacy of a Manualized Reflective Writing Program for Clinical Phase Physician Assistant (PA) Students.
NCT06000488 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2025-09-02
Summary
The following will be an open label controlled efficacy trial of the effects of longitudinal participation in an existing reflective writing program for medical students on burnout in physician assistant students.
Conditions
- Burn Out
- Student Burnout
- Physician Assistant Student Burnout
Interventions
- BEHAVIORAL
-
Reflective Writing Workshop Sessions
Three workshops of 75 minutes. Trained PA and/or MD student facilitators will then use prepared materials to guide each group through a series of prompts, each eliciting written reflections of varying lengths. While all participants are encouraged to reflect, write, and share their responses, participation at all levels remains optional.
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
Mathew Chiang · Yale University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-31
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
Countries
- United States
Study Locations
More Related Trials
-
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
NCT01456468 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073368 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure
NCT00248625 ·Status: COMPLETED ·Phase: PHASE3
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
NCT00364689 ·Status: TERMINATED ·Phase: PHASE3
-
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
NCT00845845 ·Status: TERMINATED ·Phase: PHASE2
-
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
NCT01846806 ·Status: TERMINATED ·Phase: NA
-
Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
NCT02039219 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
NCT01555957 ·Status: COMPLETED ·Phase: PHASE3
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
NCT01739517 ·Status: UNKNOWN ·Phase: PHASE2
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Weight, Energy, Lipids, and the Liver (WELL) Study
NCT05199948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Intestinal Microbiome in Obese Kids
NCT00816296 ·Status: WITHDRAWN
-
Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children
NCT02337894 ·Status: WITHDRAWN ·Phase: NA
-
Treating Pediatric NAFLD with Nutrition
NCT05499585 ·Status: COMPLETED ·Phase: NA
-
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
NCT02691533 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
NCT01466894 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
Cholestasis Reversal: Efficacy of IV Fish Oil
NCT00910104 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Total Parenteral Nutrition-Associated Liver Disease
NCT00031135 ·Status: TERMINATED ·Phase: PHASE2
-
Pentoxifylline Therapy in Biliary Atresia
NCT01774487 ·Status: TERMINATED ·Phase: PHASE2
-
Early Nutrition in Acute Pancreatitis
NCT03820128 ·Status: UNKNOWN ·Phase: NA
-
Lipid Emulsions and Liver Function - Results After 5 Years.
NCT04347902 ·Status: COMPLETED ·Phase: PHASE4